These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 17689752

  • 1. Bone mineral density, bone remodeling and osteoprotegerin in patients with acute coronary syndrome.
    Pérez-Castrillon JL, Abad L, Vega G, Sanz-Cantalapiedra A, San Miguel A, Mazón A, De Luis D, Dueñas-Laita A.
    Int J Cardiol; 2008 Sep 16; 129(1):144-5. PubMed ID: 17689752
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F, De la Vega-Prieto MJ, Milena-Abril A, Sánchez-Pérez MJ, Martínez-Riera A, Gómez-Rodríguez Mde L.
    Alcohol Alcohol; 2006 Sep 16; 41(3):261-6. PubMed ID: 16476762
    [Abstract] [Full Text] [Related]

  • 7. Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.
    Ricci P, Tauchmanova L, Risitano AM, Carella C, Mazziotti G, Lombardi G, Colao A, Rotoli B, Selleri C.
    Transplantation; 2006 Dec 15; 82(11):1449-56. PubMed ID: 17164716
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome.
    Pérez-Castrillón JL, Vega G, Abad L, Sanz-Cantalapiedra A, Gonzalez Sagredo M, de Luis D, Duenas-Laita A.
    Ann Nutr Metab; 2008 Dec 15; 53(2):117-21. PubMed ID: 18997459
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
    Mencej-Bedrac S, Prezelj J, Kocjan T, Teskac K, Ostanek B, Smelcer M, Marc J.
    J Mol Endocrinol; 2009 Mar 15; 42(3):239-47. PubMed ID: 19131500
    [Abstract] [Full Text] [Related]

  • 12. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y, Onouchi T, Ikeda T, Adachi J, Tamura Y, Horiuchi T.
    Gerontology; 2009 Mar 15; 55(3):275-80. PubMed ID: 19158438
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
    Wang J, Wang K, Shi Z, Zhang M.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct 15; 22(10):1161-4. PubMed ID: 18979868
    [Abstract] [Full Text] [Related]

  • 15. Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women.
    D'Amore M, Fanelli M, D'Amore S, Fontana A, Minenna G.
    Panminerva Med; 2006 Dec 15; 48(4):215-21. PubMed ID: 17215793
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
    Kiechl S, Werner P, Knoflach M, Furtner M, Willeit J, Schett G.
    Expert Rev Cardiovasc Ther; 2006 Nov 15; 4(6):801-11. PubMed ID: 17173497
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.